摘要
目的:观察降纤酶联合谷红注射液治疗急性脑梗死的疗效与安全性。方法:以随机抽样法将急性脑梗死患者76例分为2组(治疗组和对照组)。对照组给予降纤酶10 U静脉滴注,1日/次;治疗组在此基础上辅助注射谷红注射液。2周后观察2组疗效,比较2组患者治疗前后神经功能缺损程度及血液流变学变化。结果:治疗组疗效、基本治愈率明显高于对照组(P<0.05),各项指标均显著优于对照组(P<0.05)。结论:降纤酶与谷红注射液联合应用治疗脑梗死疗效好,且用药安全。
OBJECTIVE:To evaluate the efficiency and safety of defibrase combined with Guhong injection for acute cerebral infarction. METHODS: Seventy-six patients with acute cerebral infarction were randomly assigned to receive defibrase (10 U)by intravenous drip infusion q. d alone (control group)or in combination with Guhong injection ( treatment group). After two weeks' treatment, the efficiency was evaluated and the degree of neurologic impairment and haemorheology of the two groups were compared before and after treatment. RESULTS: The curative efficacy and basic cure rate in the treatment group were significantly higher than in the control group ( P 〈 0. 05 ) and all the indicator in the treatment group were better than in the control group ( P 〈 0. 05 ). CONCLUSION : Defibrase plus Guhong injection is safe and effective in the treatment of cerebral infarction.
出处
《中国医院用药评价与分析》
2014年第1期65-66,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
关键词
脑梗死
降纤酶
谷红注射液
Cerebral infarction
Defibrase
Guhong injection